Are there specific cytologic features that can predict BRAF V600E mutational status of papillary thyroid carcinoma in fine-needle aspiration specimens?
Juliann M MendesTarik M ElsheikhJessica Di MarcoJennifer RussellTatyana GladkayaMarlo M NicolasElisha ClapacsJames Frank BenaJohn L McAfeeMaria Luisa C Policarpio-NicolasPublished in: Diagnostic cytopathology (2024)
CNPTC is sensitive but not specific for BRAF mutational status. SSN, PPC, and CNPTC are not predictive markers for the presence of BRAF mutation or histologic subtypes. Additional studies may be needed to further corroborate these findings.